The Senate voted 94-1 in favor of legislation renewing the FDA's authority to collect user fees from drug and device makers. The bill, which already cleared the House, did not include language allowing the importation of drugs from Canada, and a separate bill regarding patients' rights to try experimental treatments was passed earlier in the day.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.